Trade Today, Wedbush Reaffirm Neutral Rating for BioMarin Pharmaceutical Inc. (BMRN) - DailyQuint

Trade Today, Wedbush Reaffirm Neutral Rating for BioMarin Pharmaceutical Inc. (BMRN)
DailyQuint
Wedbush restated their neutral rating on shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) in a report published on Friday morning. Wedbush currently has a $104.00 price objective on the stock, up from their previous price objective of $102.00.
Stock Price Target Of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) At $114.75Stocks Daily
Reliable stocks in today's share market: BioMarin Pharmaceutical In